Literature DB >> 15571915

Reovirus oncolysis in human head and neck squamous carcinoma cells.

Yoichi Ikeda1, Goshi Nishimura, Shunsuke Yanoma, Akira Kubota, Madoka Furukawa, Mamoru Tsukuda.   

Abstract

OBJECTIVE: To determine whether reovirus, a double-standed RNA virus is effective on the growth of a human head and neck squamous cell carcinoma cell line. DESIGNS: In vitro cell proliferation assay, KB cells, a human oral floor squamous cell carcinoma cell line, were treated with reovirus and the number of cells was quantitated by an assay, using trypan blue staining. In vivo tumor growth assay, KB cells were injected subcutaneously into athymic nude mice, which were given an intratumoral injection of reovirus to a maximum four times in every week. The tumor size was measured once a week. Simultaneously, apoptosis and necrosis of KB cells were investigated, using technique of immunohistochemistry.
RESULTS: In vitro, the multiplication of the KB cell was inhibited depending on the concentration of reovirus. In vivo, athymic nude mice bearing KB tumors were injected with the virus intratumorally, and the tumor growth was suppressed proportionally depending on the injection time of reovirus. Necrosis was recognized extensively in the pathological specimen. On the other hand, apoptosis-inducing effect was not obvious in these specimen.
CONCLUSIONS: Reovirus suppressed tumor growth of KB cells in vivo as well as in vitro. The possibility that reovirus could become the means of treatment for head and neck carcinoma, was suggested with further work.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15571915     DOI: 10.1016/j.anl.2004.07.003

Source DB:  PubMed          Journal:  Auris Nasus Larynx        ISSN: 0385-8146            Impact factor:   1.863


  12 in total

1.  Reduction of virion-associated σ1 fibers on oncolytic reovirus variants promotes adaptation toward tumorigenic cells.

Authors:  Adil Mohamed; Carmit Teicher; Sarah Haefliger; Maya Shmulevitz
Journal:  J Virol       Date:  2015-02-04       Impact factor: 5.103

Review 2.  Clinical development of reovirus for cancer therapy: An oncolytic virus with immune-mediated antitumor activity.

Authors:  Jun Gong; Esha Sachdev; Alain C Mita; Monica M Mita
Journal:  World J Methodol       Date:  2016-03-26

3.  African Swine Fever Virus NP868R Capping Enzyme Promotes Reovirus Rescue during Reverse Genetics by Promoting Reovirus Protein Expression, Virion Assembly, and RNA Incorporation into Infectious Virions.

Authors:  Heather E Eaton; Takeshi Kobayashi; Terence S Dermody; Randal N Johnston; Philippe H Jais; Maya Shmulevitz
Journal:  J Virol       Date:  2017-05-12       Impact factor: 5.103

4.  Down-regulation of cFLIP following reovirus infection sensitizes human ovarian cancer cells to TRAIL-induced apoptosis.

Authors:  Penny Clarke; Kenneth L Tyler
Journal:  Apoptosis       Date:  2007-01       Impact factor: 4.677

5.  Oncolytic reovirus synergizes with chemotherapeutic agents to promote cell death in canine mammary gland tumor.

Authors:  Masaya Igase; Chung Chew Hwang; Satoshi Kambayashi; Masato Kubo; Matt Coffey; Takako Shimokawa Miyama; Kenji Baba; Masaru Okuda; Shunsuke Noguchi; Takuya Mizuno
Journal:  Can J Vet Res       Date:  2016-01       Impact factor: 1.310

6.  Inflammatory tumour cell killing by oncolytic reovirus for the treatment of melanoma.

Authors:  F Errington; C L White; K R Twigger; A Rose; K Scott; L Steele; L J Ilett; R Prestwich; H S Pandha; M Coffey; P Selby; R Vile; K J Harrington; A A Melcher
Journal:  Gene Ther       Date:  2008-04-10       Impact factor: 5.250

Review 7.  Progress in oncolytic virotherapy for the treatment of thyroid malignant neoplasm.

Authors:  Mingxu Guan; Gaetano Romano; Roberta Coroniti; Earl E Henderson
Journal:  J Exp Clin Cancer Res       Date:  2014-11-01

8.  Oncolytic activity of reovirus in HPV positive and negative head and neck squamous cell carcinoma.

Authors:  Timothy Cooper; Vincent L Biron; David Fast; Raymond Tam; Thomas Carey; Maya Shmulevitz; Hadi Seikaly
Journal:  J Otolaryngol Head Neck Surg       Date:  2015-02-24

Review 9.  Activated ras signaling pathways and reovirus oncolysis: an update on the mechanism of preferential reovirus replication in cancer cells.

Authors:  Jun Gong; Monica M Mita
Journal:  Front Oncol       Date:  2014-06-26       Impact factor: 6.244

Review 10.  Potential for Improving Potency and Specificity of Reovirus Oncolysis with Next-Generation Reovirus Variants.

Authors:  Adil Mohamed; Randal N Johnston; Maya Shmulevitz
Journal:  Viruses       Date:  2015-12-01       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.